By slowing the movement of food through the digestive system, semaglutide and tirzepatide extend feelings of fullness, helping patients naturally reduce their calorie intake
Who Should Avoid It Dont use semaglutide if you have: Personal or family history of medullary thyroid carcinoma (a specific thyroid cancer) Multiple endocrine neoplasia syndrome type 2 Any pregnancy plans (stop at least 2 months before trying to conceive) Talk to your doctor if you have a history of pancreatitis, kidney disease, diabetic retinopathy, or gallbladder problems
The researchers conclude that AI-driven analysis of social media could serve as an early warning system, especially for medications or health products that gain widespread use quickly
CagriSema has completed Phase 3 trials and Novo Nordisk is expected to file for FDA approval
Your provider will ensure there are no contraindications
GIP receptor activation appears to amplify the metabolic benefits beyond what GLP-1 agonism alone can achieve, which is why tirzepatide consistently outperforms semaglutide in head-to-head comparisons